Albers Ruud, Antoine Jean-Michel, Bourdet-Sicard Raphaëlle, Calder Philip C, Gleeson Michael, Lesourd Bruno, Samartín Sonia, Sanderson Ian R, Van Loo Jan, Vas Dias F Willem, Watzl Bernhard
Unilever Health Institute, PO Box 114, NL 3130 AC Vlaardingen, The Netherlands.
Br J Nutr. 2005 Sep;94(3):452-81. doi: 10.1079/bjn20051469.
Normal functioning of the immune system is crucial to the health of man, and diet is one of the major exogenous factors modulating individual immunocompetence. Recently, nutrition research has focused on the role of foods or specific food components in enhancing immune system responsiveness to challenges and thereby improving health and reducing disease risks. Assessing diet-induced changes of immune function, however, requires a thorough methodological approach targeting a large spectrum of immune system parameters. Currently, no single marker is available to predict the outcome of a dietary intervention on the resistance to infection or to other immune system-related diseases. The present review summarises the immune function assays commonly used as markers in human intervention studies and evaluates their biological relevance (e.g. known correlation with clinically relevant endpoints), sensitivity (e.g. within- and between-subject variation), and practical feasibility. Based on these criteria markers were classified into three categories with high, medium or low suitability. Vaccine-specific serum antibody production, delayed-type hypersensitivity response, vaccine-specific or total secretory IgA in saliva and the response to attenuated pathogens, were classified as markers with high suitability. Markers with medium suitability include natural killer cell cytotoxicity, oxidative burst of phagocytes, lymphocyte proliferation and the cytokine pattern produced by activated immune cells. Since no single marker allows conclusions to be drawn about the modulation of the whole immune system, except for the clinical outcome of infection itself, combining markers with high and medium suitability is currently the best approach to measure immunomodulation in human nutrition intervention studies. It would be valuable to include several immune markers in addition to clinical outcome in future clinical trials in this area, as there is too little evidence that correlates markers with global health improvement.
免疫系统的正常运作对人类健康至关重要,而饮食是调节个体免疫能力的主要外部因素之一。最近,营养研究聚焦于食物或特定食物成分在增强免疫系统对挑战的反应能力方面的作用,从而改善健康状况并降低疾病风险。然而,评估饮食引起的免疫功能变化需要一种全面的方法,针对广泛的免疫系统参数。目前,尚无单一标志物可用于预测饮食干预对感染抵抗力或其他免疫系统相关疾病的影响。本综述总结了在人体干预研究中常用作标志物的免疫功能检测方法,并评估了它们的生物学相关性(例如与临床相关终点的已知相关性)、敏感性(例如个体内和个体间的变异)以及实际可行性。基于这些标准,标志物被分为高、中、低适用性三类。疫苗特异性血清抗体产生、迟发型超敏反应、唾液中疫苗特异性或总分泌型IgA以及对减毒病原体的反应,被归类为高适用性标志物。中等适用性的标志物包括自然杀伤细胞细胞毒性、吞噬细胞的氧化爆发、淋巴细胞增殖以及活化免疫细胞产生的细胞因子模式。由于除了感染本身的临床结果外,没有单一标志物能够得出关于整个免疫系统调节的结论,因此将高适用性和中等适用性的标志物结合起来是目前在人体营养干预研究中测量免疫调节的最佳方法。在该领域未来的临床试验中,除了临床结果外纳入多种免疫标志物将很有价值,因为将标志物与整体健康改善相关联的证据太少。